Market News / Story
Viatris to Acquire Pacira BioSciences in $36.50-Per-Share Cash Tender Offer
·
Viatris entered into an Agreement and Plan of Merger to acquire Pacira BioSciences via a cash tender offer at $36.50 per share, followed by a back-end merger under Delaware law. The offer will be open for 10 business days and is conditioned on a majority of shares being tendered, HSR clearance, and other customary conditions; there is no financing condition. After the tender offer closes, a merger under Section 251(h) will make Pacira a wholly owned subsidiary of…